Hepatitis B Drug Shows 20% Cure Rate in Breakthrough Trial

A new drug has functionally cured chronic hepatitis B in one in five patients, offering hope for the 254 million people living with the world's most common liver infection.

The FDA is expected to decide on approval by October 2026.